SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD)
ACAD 25.04+0.9%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sim1 who wrote (253)3/23/2006 5:02:45 PM
From: tuck   of 588
 
Looks pretty solid to me, and the stock is up a bit after hours. Don't know how important the SAPS is. Not stat sig there, but a trend, and stat sig if one uses relative rather than absolute measure from baseline. That sounds a bit like lying with statistics, but I'll defer to someone like BioKruncher on that. CGI-S reduction in treatment group could be just noise. Still, the primary endpoint was met, though with that endpoint being non-inferiority, it can't really be called a big win. After hours action -- mildly positive -- would seem to reflect this. In any case, these results certainly support further development. Anyone else got opinions?

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext